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Abstract
Background: Our understanding of the mechanisms that protect the developing embryo from intrauterine stress is 
limited. Recently, adenosine has been demonstrated to play a critical role in protecting the embryo against hypoxia via 
adenosine A1 receptors (A1ARs), which are expressed in the heart, nervous system, and other sites during 
development. However, the sites of A1AR action that mediate embryo protection are not known. To determine if the 
heart is a key site of adenosine-mediated embryo protection, A1ARs were selectively deleted in the embryonic heart 
using a Cre-LoxP system in which the alpha-myosin heavy chain promoter drives Cre-recombinase expression and 
excision of the A1AR gene from cardiomyocytes.
Results: With increasing exposure of maternal hypoxia (10% O2) from 48-96 hours beginning at embryonic day (E) 8.5, 
embryo viability decreased in the cardiac-A1AR deleted embryos. 48 hours of hypoxia reduced embryonic viability by 
49% in embryos exposed from E10.5-12.5 but no effect on viability was observed in younger embryos exposed to 
hypoxia from E8.5-10.5. After 72 hours of hypoxia, 57.8% of the cardiac-A1AR deleted embryos were either dead or re-
absorbed compared to 13.7% of control littermates and after 96 hours 81.6% of cardiac-A1AR deleted embryos were 
dead or re-absorbed. After 72 hours of hypoxia, cardiac size was reduced significantly more in the cardiac-A1AR deleted 
hearts compared to controls. Gene expression analysis revealed clusters of genes that are regulated by both hypoxia 
and A1AR expression.
Conclusions: These data identify the embryonic heart as the critical site where adenosine acts to protect the embryo 
against hypoxia. As such these studies identify a previously unrecognized mechanism of embryo protection.
Background
Hypoxia is a common fetal stressor that can be caused by
placental insufficiency, maternal smoking, anemia, cord
compression, preeclampsia, and living at high altitude [1].
Increasing evidence indicates that hypoxia can have pro-
found effects on embryogenesis and influence cardiac
development [2,3]. Hypoxic exposure of chicken embryos
for the first 3.5 days (an equivalent of embryonic day (E)
10.5 in mouse), leads to reduced embryonic viability,
growth inhibition, and altered cardiac function [4]. Long
exposure to hypoxia later in development also effects car-
diac development, heart function and leads to dilated car-
diomyopathy [5]. Fetal hypoxia in mammals results in
intrauterine growth retardation and reduced birth weight
[1,6]. We also observe that hypoxia disproportionately
reduces cardiac growth in embryos [3].
Evidence indicates that adenosine plays important role
mediating effects of hypoxia during development [2,3,7].
Adenosine levels are dynamically regulated and increase
markedly in hypoxia [8]. Adenosine acts through specific
G protein-coupled receptors, including A1 adenosine
receptors (A1ARs), which are activated by slight
increases in adenosine levels [9,10]. A1ARs are expressed
in cardiac tissue very early in embryogenesis and can reg-
ulate fetal heart function [11,12]. A1ARs are expressed in
the myocardium of developing hearts beginning at E8
and cardiac A1AR expression continues throughout
development [12]. In adults, over-expression of A1ARs
protects the heart from ischemic/reperfusion injury, and
the loss of A1ARs impairs ischemic tolerance [13,14].
We previously demonstrated that A1ARs play an essen-
tial role in protecting the embryo from hypoxia [3].
Whereas A1AR-deficient embryos do not display birth
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defects or growth restriction under normoxic conditions
[15], embryos with global deletion of A1ARs (A1AR-/-)
are severely growth retarded and have reduced viability
[3]. In addition, A1AR-/- embryos expressed less stabi-
lized hypoxia-inducible factor 1α (HIF1α) protein under
hypoxic conditions and have abnormal patterns of
embryonic gene expression [3]. Because A1ARs were
deleted from all embryonic tissues in those studies, it was
not possible to localize the embryo-protective sites of
A1AR action.
During embryogenesis, A1ARs are expressed in the
nodal region, the heart, and the nervous system [12]. It is
also likely that A1ARs are expressed in other sites that
have eluded localization via methods that have been
applied. After E9.0, the embryo is dependent on the fetal
heart for adequate nutrient delivery [16]. Thus isolated
effects on the developing heart could induce global
effects on the embryo after E9.0. To test this hypothesis,
we examined the role of cardiac A1ARs in mediating
embryonic protection against hypoxia through the use of
a mouse model in which A1ARs are deleted in the heart,
using the Cre/loxP system, with Cre-recombinase expres-
sion driven by an alpha-myosin heavy chain (α-MHC)
promoter [17]. We now report that the heart is the major
site where A1AR acts to confer protection against intra-
uterine hypoxia.
Methods
Animals
All experiments approved by the Institutional Animal
Care and Use Committee (IACUC) of Yale University.
Mice lacking cardiac A1ARs were generated by homolo-
gous recombination to introduce loxP sites around the
major coding exon of the A1AR gene [18]. Cre-recombi-
nase expression produces a truncated and non-functional
A1AR gene by excising the DNA sequence between loxP
sites [18]. Cardiomyocyte-specific A1AR knockout mice
were generated by crossing A1AR-loxP mice with
αMHC-Cre mice. A1AR-loxP (floxed; A1ARfl/fl) mice
were generated and provided by Dr. R. Greene (South-
western University, Dallas TX) [18]. α-MHC-Cre mice
were provided by Dr. M. Schnieder (Baylor Medical Cen-
ter, Houston, TX). αMHC and Cre-transgenes are
expressed in the developing myocardium beginning at
E7.5 [17,19].
To generate mice with A1ARs deleted from cardiomyo-
cy t e s,  α M H C - C r e  m i c e  w e r e  b r e d  w i t h  A 1 A R fl/fl mice.
Male αMHC-Cre mice were mated with female mice
homozygous for the A1AR floxed allele (A1ARfl/fl). The F2
matings were A1ARfl/+, αMHC-Cre × A1ARfl/fl, from which
A1ARfl/fl, αMHC-Cre males were mated with A1ARfl/fl
females to produce the embryos used in these experi-
ments. This mating scheme produces litters with
embryos expressing A1ARs in the heart and embryos
without cardiac A1ARs.
Genomic DNA was isolated from tail biopsies or
embryonic yolk sacs with the DNeasy Tissue Kit from
Qiagen (Valencia, CA) [20]. Genotyping PCR was per-
formed on genomic DNA to confirm animals were
A1ARfl/fl and determine if αMHC-Cre was present. The
presence of the A1AR floxed allele was confirmed when
the forward primer (GATCCGCAAGCAGCTCAA-
CAAA) and reverse primer (AAACTCCTCTTCAGAC-
CTAATAAC) yielded a 619 bp band. The absence of the
wild type allele was assessed with the forward primer
(TGTCCTCTTCCCTTCCTGCTCCATGATTACCA)
and reverse primer (AGAGACAGCGAAGCGGCG-
GCATATCCATTT), which yielded a 2413 bp band if the
wild type allele is present. The presence of αMHC-Cre
was confirmed when the forward primer (CGATG-
CAACGAGTGATGAGG) and reverse primer
(CGCATAACCAGTGAAACAGC) yielded a 300 bp
band.
Radioreceptor Assay
To verify deletion of A1AR expression, radioreceptor
assays were performed, as described [12]. Radioreceptor
assays were performed on hearts and brains of postnatal
day (P) 7 mouse pups using the A1AR-selective ligand
[3H]DPCPX (1-3, dipropylcyclopentyl xanthine) [12].
Because of the small sizes of the embryos, it was not pos-
sible to assess embryonic cardiac expression.
In utero Hypoxia
P r e g n a n t  m i c e  w e r e  u s e d  t o  e x a m i n e  t h e  e f f e c t s  o f
hypoxia on embryos, as described [3,21]. Hypoxia has
been reported to increase the concentration of adenosine
in the circulation to 2 μM in fetal sheep [22]; however,
due to the small size of the murine embryos we were
unable to determine embryonic levels of adenosine.
Timed matings were used to obtain the appropriate stage
embryos, with embryonic (E) day 0.5 designating the day
a vaginal plug was observed. Pregnant dams were placed
in a Plexiglass chamber (Biospherix, Redfield, NY)
equipped with an oxygen sensor that maintains ambient
O2 levels between 9.5-10.5% by introducing 100% medical
grade nitrogen into the chamber [20]. This level of oxy-
gen was selected because pregnant dams tolerate this
concentration, and it has adverse effects on embryogene-
sis [3,23]. In a previous report, we validated this protocol
using Hypoxyprobe-1 [3]. These experiments demon-
strated that the partial pressure of oxygen (pO2) in
embryonic tissue was less than 10 mm Hg or less than
1.3% O2 [3]. Control animals were housed in the same
room as the hypoxia chamber in room air (21% O2). Preg-
nant dams were housed in the chamber for 48-96 hours.Wendler et al. BMC Developmental Biology 2010, 10:57
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Embryo Morphology Analysis
At the end of hypoxia or normoxia exposure, pregnant
dams were immediately euthanized with 100% CO2.
Embryos were collected in Dulbecco's phosphate buff-
ered saline (D-PBS, Invitrogen, Carlsbad, CA) and
assessed for viability. Embryos with beating hearts were
scored as alive; embryos without beating hearts were
scored as dead; when no embryo was collected from a
uterine bud, it was scored as reabsorbed. The viability
rate was calculated as the number of live embryos divided
by the total number of embryos collected, including dead
and reabsorbed.
Embryonic and cardiac morphology was assessed using
a Zeiss Stemi 2000-C dissecting microscope (Carl Zeiss,
Oberkochen, Germany). Digital images of whole embryos
were captured with an Olympus C-5060 camera (Olym-
pus, Tokyo, Japan). Quantitative measurements of the
crown-rump (CR) length were taken from photographic
prints.
Embryos were fixed, embedded in paraffin, and sec-
tioned, as described [24]. Sections were stained with Har-
ris-modified hematoxylin and Eosin Y (H&E, Fisher
Scientific, Fair Lawn, NJ), according to standard proce-
dures. Images were captured under bright field condi-
tions with an Olympus IX70 inverted microscope and
analyzed for cross sectional area of various cardiac struc-
tures using Image-Pro Plus analysis software (Media
Cybernetics, Inc., Silver Spring, MD). Area analysis was
taken from sagittal sections of embryos at the level of the
junction of the atrioventricular (AV) canal and the ventri-
cle. The area of the ventricular myocardium, AV canal
cushions or outflow tract (OFT) cushions were outlined
and the area determined by imaging software. Every third
section was analyzed, and 5-6 sections per embryo were
quantitated. The average area for each cardiac structure
was determined for each embryo.
Microarray Analysis
Total RNA was purified from isolated hearts exposed to
in utero hypoxia (10% O2) for 24 hours from E9.5 to
E10.5, as described [3]. RNA was collected from at least
10 hearts from each group (Normox/Flox, Normox/Cre,
Hypox/Flox, and Hypox/Cre). The RNA was then pro-
vided to the W. M. Keck Foundation Biotechnology
Resource Laboratory at Yale University for analysis. Gene
expression analysis was performed using the Illumina
microarray gene chip Mouse 6 (Illumina Inc., San Diego,
CA), which interrogates the whole mouse genome of over
30,000 genes. Each analysis was run in triplicate. Changes
in gene expression (fold change) and p-values were calcu-
lated using Partek software (St. Louis, MO) at the Y ale
Center for Statistical Genomics and Proteomics. Analysis
of gene pathways was performed using Metacore soft-
ware (Genego Pathway Analysis Inc., San Diego, CA).
Statistical Analysis
Data are presented as means +/- the standard error of the
mean (SEM). Analyses were performed with the statistics
software package included with Microsoft Excel (Micro-
soft, Edmond, WA) and GraphPad Prism (GraphPad
Software Inc., San Diego, CA). Statistical comparisons
between groups were performed with student t tests (two
sample assuming equal variances), ANOVA, or the
Mann-Whitney test. P < 0.05 was considered to be statis-
tically significant.
Results
Deletion of cardiac A1ARs results in reduced embryonic 
viability in hypoxia
We first verified deletion of A1AR expression in the heart
by radioreceptor assay [12], using the A1AR-selective
ligand [3H]DPCPX (1-3, dipropylcyclopentyl xanthine)
[12]. In the A1ARfl/fl mice, the concentration of A1ARs in
brain and heart were 28.2 + 4.2 and 2.2 + 1.1 fmol/mg of
protein, respectively. However, in the A1ARfl/fl, αMHC-Cre
mice, concentrations of A1ARs in brain and heart were
29.7 + 3.0 and 0.0 + 0.0 fmol/mg of protein, respectively.
Thus, there is no A1AR expression in the hearts of the
A1ARfl/fl, αMHC-Cre mice.
To examine the role of cardiac A1ARs in protecting the
developing embryo from hypoxia, pregnant dams were
exposed to hypoxia for 48, 72, or 96 hours. We first exam-
ined the viability of embryos following hypoxic exposure.
Each embryo or uterine bud was scored as either alive
(heart beating), dead (embryo intact but no beating
heart), or reabsorbed (no recognizable tissue inside a
uterine bud.
When pregnant dams were treated for 48 hours from
E8.5 to E10.5, there were no significant differences
between normoxia (room air) and hypoxia (10% O2)
exposure in the percentage of live embryos (Fig. 1A). The
viability (percentage of live embryos) for the 48 hours
groups was 86.4% (51 alive out of 59 total embryos) for
normoxia and 81.3% (39/47) for hypoxia treatment
groups, respectively. These percentages are consistent
with what we observed for all normoxia groups exam-
ined, and ranged from 80-90% viability.
We next examined effects of 72 hours of hypoxic expo-
sure in utero, from E8.5-11.5. 88.1% (82/93) of embryos in
normoxic dams were viable, and 42.2% (35/83) were via-
ble in the hypoxia-exposed dams (Fig. 1B). This decrease
in viability was reflected in an increase in the number of
dead embryos and an increase in the number of reab-
sorbed embryos (Fig. 1B). The low level of dead embryos
4.3% (4/93) and reabsorbed embryos 7.5% (7/93) in room
air increased to 28.9% (24/83) for both dead and reab-
sorbed embryos after 72 hours of hypoxia (Fig. 1B).Wendler et al. BMC Developmental Biology 2010, 10:57
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To confirm that reduced viability was due to the loss of
cardiac A1ARs, A1ARfl/fl  females were mated with
A1ARfl/fl males without the Cre-recombinase gene. When
we examined the litters from A1ARfl/fl matings exposed to
72 hours of hypoxia, embryo viability was 85.4% (41/48)
similar to that of the normoxia/Cre group (Fig. 1B). Thus,
loss of viability is A1AR dependent.
We next examined the effects of 96 hours of hypoxia.
Previous work examining the role of A1AR in protecting
the embryo from hypoxic stress demonstrated reduced
viability and increased percentage of reabsorbed embryos
after 96 hours of hypoxia in the A1AR global knockout
(KO) mouse model [3]. Four days of hypoxia exposure
from E8.5-12.5 caused a significant decrease in embryo
viability and an increase in embryo re-absorption in the
cardiac specific A1AR KO mice (Fig. 1C). Compared with
72 hours, 96 hours of hypoxia had a much greater adverse
effect on viability; the viability for 96 hours went from
83.8% (31/37) in room air to only 18.4% (7/38) in hypoxia
(Fig. 1C).
To further define periods of vulnerability, we examined
hypoxia from E10.5-12.5, 48 hours of hypoxia in older
embryos also reduced viability to 50.8% (33/65) and
increased re-absorption of embryos to 36.9% (24/65, Fig.
1C). This finding is in contrast to the viability observed
for the 48 hours of hypoxia treatment earlier in develop-
ment from E8.5-10.5 (81.3%). These observations indicate
that the period of E10.5-12.5 is when embryo protection
against hypoxia is most dependent on cardiac A1ARs.
Influences on cardiac development
Previous work has demonstrated that hypoxia exposure
early in embryogenesis leads to growth retardation and
reduced cardiac tissue growth, both of which are exacer-
bated by the global loss of A1ARs [3,21]. To test if dele-
tion of cardiac A1ARs mediated effects on embryonic
and cardiac growth, we assessed the CR length of
embryos following 48, 72, and 96 hours of hypoxia and
cardiac tissue area after 72 hours of hypoxia. CR lengths
and heart size measurements were obtained from live
embryos only. Four groups of embryos were analyzed: 1)
Normoxia A1ARfl/fl (Normox/Flox) dams reared in room
air. 2) Normoxia A1ARfl/fl, αMHC-Cre (Normox/Cre) dams
reared in room air and A1ARs deleted in cardiomyocytes.
3) Hypoxia A1ARfl/fl ( H ypo x/F lo x)  da m s  r ea r ed in 10%
O2. 4) Hypoxia A1ARfl/fl, αMHC-Cre (Hypox/Cre), dams
reared in 10% O2 and A1ARs deleted in cardiomyocytes.
After 48 hours of hypoxia from E8.5-10.5, there was no
significant difference in CR lengths compared to nor-
moxia controls. There are no differences among all four
groups (Fig. 2). However, hypoxia for 48 hours from
E10.5-12.5 resulted in significant embryo growth inhibi-
tion as compared to room air controls (Fig. 2). Both the
Figure 1 Cardiac specific knockout of A1AR reduces embryonic 
viability under hypoxic conditions. Pregnant dams were reared in 
room air or hypoxia (10% O2) for 2, 3, or 4 days beginning at E8.5. (A) 2-
day treatment from E8.5-10.5, no difference in viability between nor-
moxia and hypoxia, P > 0.05. (B) 3-day treatment from E8.5-11.5, hypox-
ia induced a decrease in viability of 52% in the A1AR cardiac-specific 
knockout mice but not in the normal A1AR expressing (Hypoxia +/+) 
litters. (C) 4-day treatment from E8.5-12.5, hypoxia caused a greater re-
duction in viability of 78% compared to normoxia controls. In addition, 
2-day treatment from E10.5-12.5 induced a significant decrease in via-
bility of 40% that was not seen in the younger 2-day treated (E8.5-10.5) 
embryos. *, P ≤ 0.05 by Mann-Whitney test with a 99% confidence lev-
el.
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Hypox/Cre and the Hypox/Flox groups were growth
retarded by about 15% after 48 hours of hypoxia at these
later stages, but there was no difference between these
two hypoxia groups (p > 0.05; Fig. 2).
After 72 hours of hypoxia, from E8.5-11.5, both the car-
diac A1AR KO embryos and the control littermates
exhibited significant growth retardation, with CR length
3 0 %  l e s s  t h a n  r o o m  a i r  c o n t r o l s  ( F i g.  2 E ) .  N o  s p e c i f i c
gross morphological defects were identified in the 72
hours hypoxic embryos (Fig. 2A-D). Although both Cre
and non-Cre embryos were affected by hypoxia, there
were no differences in crown-rump length between the
Hypox/Cre and Hypox/Flox groups after 72 hours of
hypoxia (Fig. 2). This observation may be due to the fact
that only live embryos were measured and some of the
more severely affected embryos were not counted. This
issue would affect the Cre group more, as they have a
higher rate of dead and re-absorbed embryos.
When we examined heart morphology, we observed
retarded heart growth in embryos lacking cardiac A1ARs
under hypoxia, compared to embryos with cardiac
A1ARs. Embryos exposed to hypoxia for 72 hours from
E8.5-11.5 were studied as described [3]. 72 hours of expo-
sure was chosen for this analysis, as no discernable effects
on embryonic growth were seen with 48 hours (from
E8.5-10.5), and 96 hours of hypoxia exposure led to
greatly decreased viability.
We measured three areas of hearts to determine the
effects of hypoxia and loss of cardiac expression of A1AR
on the growth of the developing heart. We calculated the
average area of the myocardium throughout the heart
and in the AV canal region of the heart. In addition, the
areas of both the AV canal and outflow tract (OFT) car-
diac cushions were measured.
Our analysis demonstrated a decrease in cardiac myo-
cardium by 25% for both total and AV canal region myo-
cardial tissue in the Hypoxia/Flox group compared to the
control Normox/Flox group (Fig. 3). The Hypox/Cre
group showed an even greater reduction in size of 65% for
total and 52% for AV region myocardium compared to its
control group Normox/Cre (Fig 3). Histological analysis
confirmed the marked decrease in size of the Hypox/Cre
hearts and the disrupted morphology compared to the
Hypox/Flox hearts, which demonstrate reduced size but
display normal overall morphology similar to room air
controls (Fig. 3A-D). The cardiac cushions, both AV and
OFT, were also analyzed, and the Hypox/Flox group had a
similar, 30% and 26%, respectively, decrease in area as
seen for myocardial analysis tissue (Fig. 3E).
Because of decreased viability of the Hypox/Cre group,
fewer hearts were analyzed by this method, and there was
not enough tissue to accurately measure the AV canal and
OFT cushions. These data indicate that although the
overall growth inhibition of the whole embryo observed
with hypoxia exposure is not exacerbated by the loss of
cardiac A1AR expression, the growth and morphology of
the heart is adversely affected by hypoxia to a greater
degree when A1ARs were deleted from cardiomyocytes.
96 hours of hypoxia caused an even greater reduction
in growth but few embryos were collected and measured.
The average crown rump length of Hypox/Flox embryos
exposed to hypoxia for 96 hours, from E8.5-12.5, was
decreased by 34% to 5.7 mm (± 0.29, N = 5), which is
extremely significant compared to 8.6 mm for Normox/
Flox embryos (P ≤ 3.7 × 10-6). There were not enough 96
Figure 2 Hypoxia exposure for three days induces embryonic 
growth retardation. (A) Embryos exposed to hypoxia for 2 days in ute-
ro from E8.5-10.5 were not growth retarded compared to room air con-
trols, but embryos exposed to hypoxia in utero from E10-12.5 exhibited 
significant growth retardation. Embryos exposed to hypoxia for 3 days 
demonstrated an even greater amount of growth retardation com-
pared to controls. (B-E) Representative pictures of the different treat-
ment and genotype groups after 3 days are shown. Normoxic embryos 
both (B) Normox/Flox and (C) Normox/Cre displayed normal morphol-
ogy and growth. The hypoxic embryos (D) Hypox/Flox and (E) Hypox/
Cre were significantly growth retarded, however there was no differ-
ence between Hypox/Flox and Hypox/Cre embryos. Cre/+ embryos 
have A1AR deleted from cardiomyocytes. *, P ≤ 0.01; **, P ≤ 0.001. Scale 
bar is 1 mm.
A
D C
C
Cre Flox
B
Flox
D
Cre
E
0
1
2
3
4
5
6
7
8
9
10
Normoxia
Flox
Normoxia
Cre
Hypoxia
Flox
Hypoxia
Cre
Treatment/Genotype
C
r
o
w
n
-
R
u
m
p
 
L
e
n
g
t
h
 
(
m
m
)
E8.5-10.5 E10.5-12.5 E8.5-11.5
** **
* *
N
 
=
 
7
N
 
=
 
3
2
N
 
=
 
1
3
N
 
=
 
1
5
N
 
=
 
3
3
N
 
=
 
1
1
N
 
=
 
2
0
N
 
=
 
1
7
N
 
=
 
1
8
N
 
=
 
1
8
N
 
=
 
1
9
N
 
=
 
1
9
AWendler et al. BMC Developmental Biology 2010, 10:57
http://www.biomedcentral.com/1471-213X/10/57
Page 6 of 10
hours Hypox/Cre embryos to analyze for crown-rump
length. These data indicate that hypoxia inhibits overall
embryonic growth but the loss of cardiac A1AR expres-
sion does not exacerbate hypoxic growth inhibition.
A1AR-mediated gene expression
Microarray analysis was performed on RNA collected
from hearts following 24 hours of hypoxia exposure to
identify molecular pathways involved in A1AR-mediated
embryonic protection. Genes with altered expression in
A1AR-deleted hearts were involved in biological path-
ways important for hypoxia responsiveness and normal
heart development (Table 1).
T w o  s e t s  o f  g e n e s  w e r e  i d e n t i f i e d  t o  h a v e  a l t e r e d
expression with the loss of A1AR gene expression: In the
first set, gene expression was influenced by hypoxia when
A1ARs were not expressed in the cardiomyocytes (Table
2). The second set of genes had altered expression with
the loss of A1AR expression either under hypoxic or nor-
moxic conditions (Table 3). Genes with altered expres-
sion include, myosin heavy chain alpha (Myh6) and
myosin heavy chain beta (Myh7), both of which are
important for cardiac development and they are
expressed throughout the heart early in development but
become more restricted as development continues [25].
The expression of these myosin genes was disrupted by
the loss of cardiac A1ARs. Myh6, which normally
decreases at E10.5, was up regulated in hearts without
A1ARs (Table 3). In comparison, Myh7 was down regu-
lated in A1AR deleted hearts compared to hearts with
A1AR expression (Table 3).
Discussion
A1ARs are not critical for normal embryonic or cardiac
development in normoxic conditions, as deletion of
A1ARs throughout the embryo does not result in birth
defects or growth retardation under normal circum-
stances [15]. During hypoxia however, A1ARs play an
essential role in protecting the embryo [3]. Studying
murine embryos lacking A1ARs in the heart, we now
identify the heart as the critical region where A1ARs act
to confer embryo protection.
Previous studies indicate that embryo viability was
greatly decreased after 96 hours of hypoxia when A1AR
was deleted globally [3]. In the current studies, we exam-
ined the viability of cardiac-deleted A1AR mice after 48,
72, and 96 hours of hypoxia exposure (10% O2). We found
that after 48 hours of hypoxia from E8.5-10.5, there was
no difference in viability between normoxia and hypoxia
treated embryos. Since the heart becomes more impor-
tant for nutrient delivery and embryo survival as embryo-
genesis proceeds, we examined whether 48 hours of
exposure later in development, from E10.5-12.5, could
affect embryonic viability. Two days later in development,
the embryo is more susceptible to hypoxic stress, as
embryos exposed to hypoxia from E10.5-12.5 had a 40%
decrease in viability compared to room air controls.
After 72 hours of hypoxia, from E8.5-11.5, we observed
a dramatic decrease in embryo viability compared to
room air controls. We were able to determine the geno-
type of live embryos by testing yolk sac DNA, but we
were not able to genotype all the dead and reabsorbed
embryos. Since we were unable to determine that only
Cre-expressing embryos were dying, we mated A1ARfl/fl
mice with each other. These mice did not express Cre-
Figure 3 Loss of A1ARs in cardiac tissue leads to reduced heart 
tissue under hypoxic conditions. Pregnant dams were exposed to 
hypoxia for 3 days from E8.5-E11.5 before embryos were collected. (A) 
Using Image-Pro Plus software, the cross-sectional area of the ventricle 
throughout the heart and at the level of the AV canal was measured as 
well as the area of the AV and OFT cardiac cushions. Hypoxia caused a 
25% decrease in the area of myocardial tissue both overall and at the 
level of the AV canal in the Hypox/Flox group. In the Hypox/Cre group, 
with A1AR deleted from cardiomyocytes, the decrease in area was 
more severe, 65% overall and 52% at the level of the AV canals. The AV 
canal cushions (30%) and OFT cushions (26%) were reduced in size in 
the Hypox/Flox group. Both room air groups (B) Normox/Flox and (C) 
Normox/Cre exhibited normal morphology and size. (D) Hypox/Flox 
hearts were normal in morphology but truncated in size, where as the 
(E) Hypox/Cre hearts displayed disrupted morphology and severely re-
duced size. *, P ≤ 0.05; **, P ≤ 0.01 by student's t-test. Scale bar is 200 
μm.
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recombinase, therefore cardiac A1AR expression was
normal. Under hypoxic conditions, the viability of non-
Cre litters was the same as room air control litters, indi-
cating that the loss in viability observed in the cardiac
A1AR knockout litters was due to the loss of A1AR and
not hypoxic exposure alone. Finally, we examined embry-
onic viability after 96 hours of hypoxia exposure, from
E8.5-12.5, in this case the viability was much less than the
72-hour hypoxia group with less than 1 in 5 embryos sur-
viving. These results are similar to that observed with the
global knockout of A1AR after 96 hours of hypoxia [3].
Collectively these data indicate that older embryos are
more susceptible to hypoxic insults, and cardiac A1ARs
are critical in protecting embryos from hypoxic condi-
tions.
Next, we analyzed embryonic growth of all live
embryos collected by measuring the crown-rump length.
After 48 hours of treatment between E8.5-10.5, there
were no differences in CR lengths, the same result as that
seen with embryo viability at this stage. However, hypoxic
exposure for 48 hours later in development caused a
small but significant decrease in embryo size compared
to room air controls, but no difference between the
hypoxia groups with and without cardiac A1AR expres-
sion was observed. Growth inhibition was also analyzed
after 72 hours of hypoxia, from E8.5-11.5, embryos were
more severely growth retarded than the later 48 hours of
hypoxia exposure but again no differences between the
hypoxia exposed groups were observed. Due to the poor
viability of 96 hours hypoxia exposed embryos, we could
not get an accurate measure of the crown-rump length.
These data are consistent with results for non-transgenic
C57Bl/6 mice exposed to hypoxia for 72 hours, which
showed a 24% growth inhibition [3].
Although cardiac A1ARs are critical for viability during
hypoxic stress, their loss does not increase the amount of
growth inhibition seen with hypoxia treatment. The
growth inhibition observed in the cardiac A1AR knock-
out mice is consistent with that in wildtype mice (C57Bl/
6 strain) exposed to hypoxia [3]. We previously reported
that global loss of A1ARs affects overall embryonic
growth above and beyond what is observed in non-trans-
genic mice exposed to hypoxia for 96 hours [3]. However,
that previous report only classified embryos into two cat-
egories, collected embryos and re-absorbed embryos, and
did not make a determination of whether the collected
embryos were alive or dead. This current report classifies
embryos into three categories, live, dead, and re-
absorbed. So when embryonic growth, as measured by
crown-rump length, is compared only between live
embryos of the different genotypes, the loss of cardiac
A1AR does not exacerbate hypoxia growth inhibition.
These data indicate that hypoxia growth inhibition is a
general effect of hypoxia and that reduced viability in
hypoxia is specific for the loss of A1AR in the heart.
The loss of cardiac A1ARs has severe adverse effects on
heart development. 72 hours of hypoxia exposure from
E8.5-11.5 causes a 65% decrease in myocardial tissue in
hearts not expressing A1ARs compared to only a 25%
decrease in cardiac tissue in hearts expressing A1ARs.
There was also a decrease in the size of the cardiac cush-
ions following hypoxia in hearts expressing A1ARs, how-
ever hearts without A1AR expression were too small and
malformed to measure the cardiac cushion tissue accu-
rately. These data indicate that the loss of A1ARs in cardi-
omyocytes is having severe adverse effects on cardiac
development when the embryo is exposed to hypoxic
conditions. Reduced cardiac tissue could be leading to
abnormal function of the embryonic heart and that
maybe why there is reduced viability at the later stages of
development when cardiac function becomes critical for
embryonic survival.
Because of the small sizes of the embryos studied, it
was not possible for us to directly assess levels of the
other adenosine receptors in the myocardium. However,
during early embryogenesis, only A1ARs are known to be
expressed in the heart [12]. In studies of global A1AR-/-
mice, changes in the expression of other adenosine recep-
tors have not been observed [15]. Due to technical limita-
tions, it was also not possible for us to assess adenosine
levels in the normoxic or hypoxic embryos.
Gene expression analysis revealed sets of genes in the
heart that are misregulated during hypoxia exposure
when A1ARs are not expressed. For example, there are
genes that are misregulated with the loss of A1AR expres-
sion either in hypoxic or normoxic conditions, such as
Table 1: Pathways affect by Cardiac A1AR loss.
Cellular Process/Pathway # of Genes P Value
Transcription/Role of Akt in hypoxia induced HIF1 activation 7 of 26 4.75E-04
Cytoskeleton remodeling/Regulation of actin cytoskeleton by Rho GTPases 6 of 23 1.47E-03
Glycolysis and gluconeogenesis (short map) 8 of 37 9.28E-04
Development/EPO-induced PI3K/AKT pathway and Ca(2+) influx 7 of 32 1.81E-03
Cytoskeleton remodeling Role of PKA in cytoskeleton reorganization 6 of 31 7.28E-03Wendler et al. BMC Developmental Biology 2010, 10:57
http://www.biomedcentral.com/1471-213X/10/57
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Table 2: Genes Regulated by Hypoxia and A1AR.
Probe ID Gene Hypox/Flox vs. 
Normox/Flox
P-Values Hypox/Cre vs. 
Normox/Cre
P-Values Hypoxia, A1AR, or Cardiac 
Related
ILMN_2675874 Alas2 1.91597 2.06E-06 -3.18773 2.30E-08 Hypoxia inducible
ILMN_1219154 Mt2 1.63401 0.000359711 -2.98376 1.07E-06 Hypoxia
ILMN_2596522 Mt1 2.56154 0.000118805 -2.50707 0.000139519 Hypoxia
ILMN_1250195 Ndrg1 1.9098 5.38E-06 -2.29342 8.07E-07 Hypoxia inducible
ILMN_2998934 Cited4 1.69681 8.45E-06 -2.17613 4.47E-07 Hypoxia
ILMN_2606746 Car2 1.5989 0.00168738 -2.14858 6.64E-05 Hypoxia
ILMN_2881620 Nfe2 1.87921 1.62E-06 -1.93972 1.11E-06 Cardiac
ILMN_2757966 Cxcl4 2.27996 1.05E-05 -1.89452 6.70E-05 Hypoxia inducible
ILMN_2652909 Ddit3 1.88154 0.00576158 -1.72809 0.0120442 Hypoxia inducible
ILMN_2829594 Hspa1a 2.36474 1.80E-05 -1.61118 0.00104107 Hypoxia, Cardiac
ILMN_2739544 Stc2 1.92291 2.06E-05 -1.5783 0.000261328 Hypoxia
ILMN_2605819 Egln3 2.16962 1.28E-05 -1.49541 0.00117156 Hypoxia inducible
ILMN_2643513 Asns 1.63692 5.53E-05 -1.47277 0.00029547 Hypoxia inducible
ILMN_2616565 Slc2a3 2.08188 0.000497509 -1.42853 0.0256759 Hypoxia inducible
ILMN_1249378 Bhlhb2 1.89041 4.28E-05 -1.41041 0.00250315 Hypoxia inducible
ILMN_1252762 Trib3 1.5549 2.61E-05 -1.14939 0.0267126 Hypoxia inducible
ILMN_2993109 Ddit4 1.53476 0.000963138 -1.14033 0.158638 Hypoxia inducible
ILMN_2747959 Dcn -1.59119 2.13E-06 -1.02086 0.608063 Hypoxia inducible
ILMN_1234662 Mb -1.51848 0.00354732 -1.00718 0.946075 Hypoxia inducible
ILMN_2632940 Sumo1 1.59231 1.31E-05 -1.00062 0.990303 Hypoxia, A1AR, Cardiac
ILMN_3001540 Lum -1.64593 4.50E-05 1.15664 0.0484385 Hypoxia, Cardiac
ILMN_2639036 Hspd1 1.61697 0.000950629 1.1836 0.112501 Hypoxia, Cardiac
ILMN_2763002 Eno2 1.72159 4.71E-05 1.22827 0.0171715 Hypoxia
ILMN_2677662 Hspb7 -1.89271 6.57E-05 1.59123 0.000573211 Cardiac
Myh6 and Myh7. Gene expression data thus indicates
t ha t A1AR loss could adverse ly affect cardiac deve lop -
ment by altering the expression of cardiac genes related
to cardiac function, leaving the embryo susceptible to
hypoxic stress.
Further analysis reveals another set of genes that are
miss-regulated in the A1AR deleted hearts. These genes
are normally up regulated in response to hypoxia to pro-
tect the heart from damage including heat shock proteins
60 (Hspd1) and 70 (Hspa1a), and Metallothionein (MT) 1
and 2, but in the cardiac A1AR-/- hearts their expressions
are down regulated or not changed with hypoxia treat-
ment [26-29]. A1AR signaling was demonstrated to up-
regulate MT levels during ischemia-reperfusion (I/R) and
may mediate the cardioprotective effects of A1AR agonist
preconditioning [27]. MT has been reported to stabilize
HIF protein and this may be a mechanism of cardio pro-
tection [30], and relates to the fact that we demonstrated
less stabilized HIF protein during hypoxia in the global
knockout A1AR embryos [3].
These data indicates that the mechanism by which
A1AR mediates cardio and embryonic protection during
hypoxic exposure of embryos in utero may be similar to
the mechanisms by which A1AR signaling leads to car-
dioprotection from I/R injury in adult hearts and may be
related to HIF signaling. Gene expression analysis also
indicates that the loss of A1AR signaling may leave the
heart more susceptible to hypoxia-induced damage since
increased expression of the genes associated with protec-
tion against hypoxia were not observed.
Conclusions
Our findings confirm that A1AR expression is important
for embryonic survival during hypoxic stress and that the
A1ARs expressed in the heart mediate this protection.
Disrupted cardiac development during hypoxia exposure
in cardiac A1AR deleted embryos leads to decreased
embryonic viability at stages where cardiac function is
critical for embryonic survival.Wendler et al. BMC Developmental Biology 2010, 10:57
http://www.biomedcentral.com/1471-213X/10/57
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